ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
momentum factor · long-only model fund

Foundry IntMom Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FINRHYPOTHETICAL MODEL
Since ’99
+119%
Expense Ratio
0.35%
placeholder
Holdings
296
cap-weighted
Inception
May 2022
placeholder
Full Sharpe
0.25
Ann. Return (LS)
4.7%
Ann. Volatility
19.0%
Max Drawdown
-54.9%
Test Sharpe ’19–26
0.06
Test FF5 α (ann.)
1.3%
vs Fama-French 5
Test FF5 α t-stat
0.20
not significant
Monthly turnover
41%
of the long leg, per rebalance
Cumulative return (LS)
119%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.56
what this fund holds
Long leg ann. return
13.9%
buyable, long-only
Long-short Sharpe
0.25
requires shorting
Bottom bucket ann. return
9.2%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1GOOGL
ALPHABET INCCommunication Services$4.20T
42.23%
2TSLA
TESLA INCConsumer Cyclical$1.43T
14.38%
3MU
MICRON TECHNOLOGY INCTechnology$958.80B
9.64%
4INTC
INTEL CORPTechnology$477.67B
4.80%
5LRCX
LAM RESEARCH CORPTechnology$391.80B
3.94%
6SNDK
SANDISK CORPTechnology$200.63B
2.02%
7STX
SEAGATE TECHNOLOGY HOLDINGS PLCTechnology$176.62B
1.78%
8WDC
WESTERN DIGITAL CORPTechnology$164.49B
1.65%
9APP
APPLOVIN CORPTechnology$142.62B
1.43%
10MNST
MONSTER BEVERAGE CORPConsumer Defensive$95.36B
0.96%
11GM
GENERAL MOTORS COConsumer Cyclical$68.59B
0.69%
12WBD
WARNER BROS DISCOVERY INCCommunication Services$67.37B
0.68%
13BE
BLOOM ENERGY CORPIndustrials$61.14B
0.61%
14LITE
LUMENTUM HOLDINGS INCTechnology$57.01B
0.57%
15COHR
COHERENT CORPTechnology$54.31B
0.55%
16CIEN
CIENA CORPTechnology$53.00B
0.53%
17EA
ELECTRONIC ARTS INCCommunication Services$52.38B
0.53%
18TER
TERADYNE INCTechnology$50.46B
0.51%
19RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.40%
20RKLB
ROCKET LAB CORPIndustrials$39.14B
0.39%
21NTRA
NATERA INCHealthcare$38.87B
0.39%
22TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDHealthcare$37.30B
0.37%
23RDDT
REDDIT INCCommunication Services$34.88B
0.35%
24CNC
CENTENE CORPHealthcare$32.81B
0.33%
25EXPE
EXPEDIA GROUP INCIndustrials$32.26B
0.32%
26ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
0.27%
27MDB
MONGODB INCTechnology$25.12B
0.25%
28ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.25%
29UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.23%
30RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
0.22%
31MKSI
MKS INCTechnology$21.93B
0.22%
32FTAI
FTAI AVIATION LTDIndustrials$21.28B
0.21%
33GH
GUARDANT HEALTH INCHealthcare$20.67B
0.21%
34RGLD
ROYAL GOLD INCBasic Materials$16.05B
0.16%
35AMKR
AMKOR TECHNOLOGY INCTechnology$15.60B
0.16%
36SITM
SITIME CORPTechnology$14.65B
0.15%
37ALB
ALBEMARLE CORPBasic Materials$14.24B
0.14%
38ONTO
ONTO INNOVATION INCTechnology$13.92B
0.14%
39BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.14%
40MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.13%
41U
UNITY SOFTWARE INCTechnology$12.66B
0.13%
42DOCN
DIGITALOCEAN HOLDINGS INCTechnology$12.41B
0.12%
43COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.12%
44AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.12%
45W
WAYFAIR INCConsumer Cyclical$11.79B
0.12%
46AA
ALCOA CORPBasic Materials$11.61B
0.12%
47VICR
VICOR CORPTechnology$10.83B
0.11%
48FROG
JFROG LTDTechnology$10.72B
0.11%
49ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.11%
50GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.11%
51HUT
HUT 8 CORPFinancial Services$10.30B
0.10%
52GSAT
GLOBALSTAR INCCommunication Services$10.20B
0.10%
53APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.10%
54VSAT
VIASAT INCTechnology$9.76B
0.10%
55HL
HECLA MINING COBasic Materials$9.61B
0.10%
56MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.10%
57KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.10%
58WULF
TERAWULF INCFinancial Services$9.00B
0.09%
59IONS
IONIS PHARMACEUTICALS INCHealthcare$8.99B
0.09%
60COMP
COMPASS INCTechnology$8.97B
0.09%
61VIAV
VIAVI SOLUTIONS INCTechnology$8.93B
0.09%
62PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.09%
63SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.09%
64FORM
FORMFACTOR INCTechnology$8.23B
0.08%
65PL
PLANET LABS PBCIndustrials$8.01B
0.08%
66APLD
APPLIED DIGITAL CORPFinancial Services$7.37B
0.07%
67PACS
PACS GROUP INCHealthcare$7.30B
0.07%
68CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.07%
69ENS
ENERSYSIndustrials$7.18B
0.07%
70LQDA
LIQUIDIA CORPHealthcare$7.11B
0.07%
71COGT
COGENT BIOSCIENCES INCHealthcare$6.68B
0.07%
72VFC
V F CORPConsumer Cyclical$6.65B
0.07%
73VSXY
VICTORIA'S SECRET & COConsumer Cyclical$6.47B
0.07%
74LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.07%
75PATH
UIPATH INCTechnology$6.30B
0.06%
76M
MACY'S INCConsumer Cyclical$6.23B
0.06%
77QBTS
D-WAVE QUANTUM INCTechnology$6.19B
0.06%
78KRMN
KARMAN HOLDINGS INCIndustrials$6.12B
0.06%
79ERAS
ERASCA INCHealthcare$5.96B
0.06%
80LYFT
LYFT INCTechnology$5.89B
0.06%
81ENVA
ENOVA INTERNATIONAL INCFinancial Services$5.79B
0.06%
82DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.06%
83PRM
PERIMETER SOLUTIONS INCBasic Materials$5.61B
0.06%
84ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.06%
85SSRM
SSR MINING INCBasic Materials$5.31B
0.05%
86TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.05%
87XMTR
XOMETRY INCIndustrials$5.18B
0.05%
88LMND
LEMONADE INCFinancial Services$5.16B
0.05%
89SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.05%
90LAUR
LAUREATE EDUCATION INCConsumer Defensive$5.10B
0.05%
91VCYT
VERACYTE INCHealthcare$4.72B
0.05%
92RGTI
RIGETTI COMPUTING INCTechnology$4.69B
0.05%
93LFST
LIFESTANCE HEALTH GROUP INCHealthcare$4.49B
0.05%
94LIVN
LIVANOVA PLCHealthcare$4.43B
0.04%
95CELC
CELCUITY INCHealthcare$4.31B
0.04%
96COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.04%
97HCC
WARRIOR MET COAL INCBasic Materials$4.17B
0.04%
98CENX
CENTURY ALUMINUM COBasic Materials$4.11B
0.04%
99LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.04%
100DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.04%
101LASR
NLIGHT INCTechnology$3.91B
0.04%
102LBRT
LIBERTY ENERGY INCEnergy$3.89B
0.04%
103RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.04%
104ALMS
ALUMIS INCHealthcare$3.65B
0.04%
105ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.04%
106MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.04%
107GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.03%
108RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.03%
109HP
HELMERICH & PAYNE INCEnergy$3.41B
0.03%
110FSLY
FASTLY INCTechnology$3.24B
0.03%
111ONDS
ONDAS INCTechnology$3.23B
0.03%
112WK
WORKIVA INCTechnology$3.21B
0.03%
113SHOO
STEVEN MADDEN LTDConsumer Cyclical$3.17B
0.03%
114GRAL
GRAIL INCHealthcare$3.12B
0.03%
115AXTI
AXT INCTechnology$3.00B
0.03%
116MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.03%
117DAN
DANA INCConsumer Cyclical$2.87B
0.03%
118TDC
TERADATA CORPTechnology$2.87B
0.03%
119AEO
AMERICAN EAGLE OUTFITTERS INCConsumer Cyclical$2.85B
0.03%
120RUN
SUNRUN INCTechnology$2.83B
0.03%
121VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.03%
122VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.03%
123BTU
PEABODY ENERGY CORPBasic Materials$2.73B
0.03%
124ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.03%
125ANDE
ANDERSONS INCConsumer Defensive$2.70B
0.03%
126KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.03%
127NGVT
INGEVITY CORPBasic Materials$2.66B
0.03%
128FLNC
FLUENCE ENERGY INCUtilities$2.59B
0.03%
129TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.03%
130IMNM
IMMUNOME INCHealthcare$2.53B
0.03%
131SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.02%
132ATRO
ASTRONICS CORPIndustrials$2.41B
0.02%
133ROG
ROGERS CORPTechnology$2.36B
0.02%
134PLUS
EPLUS INCTechnology$2.33B
0.02%
135NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.02%
136PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.02%
137MLYS
MINERALYS THERAPEUTICS INCHealthcare$2.23B
0.02%
138SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.02%
139DHC
DIVERSIFIED HEALTHCARE TRUSTReal Estate$2.22B
0.02%
140IMAX
IMAX CORPCommunication Services$2.15B
0.02%
141MD
PEDIATRIX MEDICAL GROUP INCHealthcare$2.15B
0.02%
142AXGN
AXOGEN INCHealthcare$2.12B
0.02%
143AVAH
AVEANNA HEALTHCARE HOLDINGS INCHealthcare$2.11B
0.02%
144OMCL
OMNICELL INCHealthcare$2.09B
0.02%
145GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.02%
146RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.02%
147NUVB
NUVATION BIO INCHealthcare$2.03B
0.02%
148SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.02%
149INFQ
INFLEQTION INCTechnology$1.98B
0.02%
150KSS
KOHLS CORPConsumer Cyclical$1.96B
0.02%
151DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.02%
152TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.02%
153NEO
NEOGENOMICS INCHealthcare$1.90B
0.02%
154NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.02%
155ZBIO
ZENAS BIOPHARMA INCHealthcare$1.86B
0.02%
156ALGT
ALLEGIANT TRAVEL COIndustrials$1.86B
0.02%
157VRDN
VIRIDIAN THERAPEUTICS INCHealthcare$1.86B
0.02%
158AMR
ALPHA METALLURGICAL RESOURCES INCBasic Materials$1.83B
0.02%
159STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.02%
160SONO
SONOS INCTechnology$1.80B
0.02%
161ZYME
ZYMEWORKS INCHealthcare$1.77B
0.02%
162HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.02%
163BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.02%
164FIGS
FIGS INCConsumer Cyclical$1.72B
0.02%
165TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.02%
166ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.02%
167FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.02%
168TE
T1 ENERGY INCIndustrials$1.63B
0.02%
169PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.02%
170MAZE
MAZE THERAPEUTICS INCHealthcare$1.56B
0.02%
171SKYT
SKYWATER TECHNOLOGY INCTechnology$1.54B
0.02%
172SEPN
SEPTERNA INCHealthcare$1.51B
0.02%
173TBLA
TABOOLACOM LTDCommunication Services$1.44B
0.01%
174KMTS
KESTRA MEDICAL TECHNOLOGIES LTDHealthcare$1.43B
0.01%
175GCT
GIGACLOUD TECHNOLOGY INCTechnology$1.40B
0.01%
176REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.01%
177BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.01%
178FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.01%
179ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.01%
180XNCR
XENCOR INCHealthcare$1.30B
0.01%
181DCH
DAUCH CORPConsumer Cyclical$1.29B
0.01%
182INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.01%
183TTI
TETRA TECHNOLOGIES INCEnergy$1.25B
0.01%
184CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.01%
185HLF
HERBALIFE LTDConsumer Defensive$1.24B
0.01%
186NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.01%
187IRMD
IRADIMED CORPHealthcare$1.24B
0.01%
188AMRC
AMERESCO INCIndustrials$1.22B
0.01%
189AORT
ARTIVION INCHealthcare$1.22B
0.01%
190DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.01%
191XPEL
XPEL INCConsumer Cyclical$1.19B
0.01%
192SVRA
SAVARA INCHealthcare$1.13B
0.01%
193CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.01%
194NUTX
NUTEX HEALTH INCHealthcare$1.12B
0.01%
195WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.01%
196UPWK
UPWORK INCIndustrials$1.12B
0.01%
197EYPT
EYEPOINT INCHealthcare$1.12B
0.01%
198RHLD
RESOLUTE HOLDINGS MANAGEMENT INCIndustrials$1.10B
0.01%
199GOLD
GOLDCOM INCFinancial Services$1.09B
0.01%
200JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.01%
201AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.01%
202BIOA
BIOAGE LABS INCHealthcare$1.01B
0.01%
203OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.01%
204FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.01%
205ABX
ABACUS GLOBAL MANAGEMENT INCFinancial Services$994M
0.01%
206ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.01%
207LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.01%
208ANNX
ANNEXON INCHealthcare$950M
0.01%
209FTK
FLOTEK INDUSTRIES INCEnergy$947M
0.01%
210PHAT
PHATHOM PHARMACEUTICALS INCHealthcare$873M
0.01%
211AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
212UAMY
UNITED STATES ANTIMONY CORPBasic Materials$809M
0.01%
213ACRS
ACLARIS THERAPEUTICS INCHealthcare$793M
0.01%
214DSGN
DESIGN THERAPEUTICS INCHealthcare$785M
0.01%
215BBNX
BETA BIONICS INCHealthcare$771M
0.01%
216RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.01%
217CSTL
CASTLE BIOSCIENCES INCHealthcare$733M
0.01%
218CLYM
CLIMB BIO INCHealthcare$727M
0.01%
219CBLL
CERIBELL INCHealthcare$710M
0.01%
220OMER
OMEROS CORPHealthcare$701M
0.01%
221MAMA
MAMA'S CREATIONS INCConsumer Defensive$700M
0.01%
222BALY
BALLY'S CORPConsumer Cyclical$688M
0.01%
223LPTH
LIGHTPATH TECHNOLOGIES INCTechnology$657M
0.01%
224FEIM
FREQUENCY ELECTRONICS INCTechnology$650M
0.01%
225TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
226ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.01%
227NVRI
ENVIRI CORPIndustrials$643M
0.01%
228AENT
ALLIANCE ENTERTAINMENT HOLDING CORPCommunication Services$641M
0.01%
229FET
FORUM ENERGY TECHNOLOGIES INCEnergy$593M
0.01%
230PACK
RANPAK HOLDINGS CORPConsumer Cyclical$583M
0.01%
231STTK
SHATTUCK LABS INCHealthcare$577M
0.01%
232ANGO
ANGIODYNAMICS INCHealthcare$558M
0.01%
233IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.01%
234RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.01%
235RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.01%
236NPCE
NEUROPACE INCHealthcare$548M
0.01%
237ELA
ENVELA CORPConsumer Cyclical$547M
0.01%
238XMAX
XMAX INCConsumer Cyclical$541M
0.01%
239CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.01%
240ZURA
ZURA BIO LTDHealthcare$518M
0.01%
241MNRO
MONRO INCConsumer Cyclical$509M
0.01%
242MG
MISTRAS GROUP INCIndustrials$500M
0.01%
243NRC
NRC HEALTHHealthcare$491M
0.00%
244AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.00%
245DIN
DINE BRANDS GLOBAL INCConsumer Cyclical$456M
0.00%
246KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.00%
247ALTO
ALTO INGREDIENTS INCBasic Materials$453M
0.00%
248MATV
MATIV HOLDINGS INCBasic Materials$442M
0.00%
249BETR
BETTER HOME & FINANCE HOLDING COFinancial Services$442M
0.00%
250PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
251ASMB
ASSEMBLY BIOSCIENCES INCHealthcare$426M
0.00%
252TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.00%
253IMXI
INTERNATIONAL MONEY EXPRESS INCTechnology$404M
0.00%
254ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.00%
255EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.00%
256DMAC
DIAMEDICA THERAPEUTICS INCHealthcare$393M
0.00%
257UPB
UPSTREAM BIO INCHealthcare$382M
0.00%
258ELMD
ELECTROMED INCHealthcare$349M
0.00%
259CV
CAPSOVISION INCHealthcare$335M
0.00%
260VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.00%
261TWIN
TWIN DISC INCIndustrials$326M
0.00%
262VELO
VELO3D INCTechnology$316M
0.00%
263ZUMZ
ZUMIEZ INCConsumer Cyclical$315M
0.00%
264LYEL
LYELL IMMUNOPHARMA INCHealthcare$311M
0.00%
265BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
266OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.00%
267DBI
DESIGNER BRANDS INCConsumer Cyclical$290M
0.00%
268ISBA
ISABELLA BANK CORPFinancial Services$288M
0.00%
269SGHT
SIGHT SCIENCES INCHealthcare$274M
0.00%
270SRZN
SURROZEN INCHealthcare$255M
0.00%
271ASYS
AMTECH SYSTEMS INCTechnology$242M
0.00%
272DUOT
DUOS TECHNOLOGIES GROUP INCTechnology$241M
0.00%
273GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.00%
274USAU
US GOLD CORPBasic Materials$235M
0.00%
275RDNW
RIDENOW GROUP INCConsumer Cyclical$229M
0.00%
276KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
277LTRX
LANTRONIX INCTechnology$207M
0.00%
278FCAP
FIRST CAPITAL INCFinancial Services$205M
0.00%
279FOCL
FOCAL INCHealthcare$204M
0.00%
280EGAN
EGAIN CORPTechnology$180M
0.00%
281INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
282STRS
STRATUS PROPERTIES INCReal Estate$165M
0.00%
283KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.00%
284OWLT
OWLET INCHealthcare$162M
0.00%
285AP
AMPCO PITTSBURGH CORPIndustrials$156M
0.00%
286VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
287SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
288WYY
WIDEPOINT CORPTechnology$115M
0.00%
289TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.00%
290CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
291INTG
INTERGROUP CORPConsumer Cyclical$84M
0.00%
292NRXS
NEURAXIS INCHealthcare$84M
0.00%
293VNCE
VINCE HOLDING CORPConsumer Cyclical$83M
0.00%
294BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
295RGS
REGIS CORPConsumer Cyclical$74M
0.00%
296LONA
LEONABIO INCHealthcare$68M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $9.95T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Communication Services
44.2%
Technology
29.8%
Consumer Cyclical
15.8%
Healthcare
5.2%
Industrials
2.2%
Consumer Defensive
1.2%
Basic Materials
0.8%
Financial Services
0.5%
Energy
0.1%
Utilities
0.0%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
<1%3
18%26
76%46
<1%20
1%46
1%49
<1%16
<1%35
<1%24

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 89% toward Growth. +2% unclassified (31 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt98% → Large
SmallLarge
Value ↔ growth tilt89% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
2
Failed
3
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    48.8%
    Margin
    -26.2%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    42.2%
    Margin
    -17.2%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    46.1%
    Margin
    -21.1%
Reported separately — arithmetically implied
  • At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.

    Required
    >= 50.0%
    Actual
    48.8%
    Margin
    -1.2%

    Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.7 (95% CI 1.2-2.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
16.2%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.68x
within
parametric
1.55x
within
cornish fisher
1.68x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2012
Before publication (pre-2012)
0.38
Sharpe · 7.9% p.a.
January 1999December 2012 · 168 mo
Since publication
0.08
Sharpe · 1.3% p.a.
January 2013July 2026 · 163 mo
Change in Sharpe−0.31Sharpe weakened since publication83% of the prior annual return given up

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
69%
18 of 26 3-year windows made money
Worst window
-0.79
Sharpe, January 2021 – December 2023
January 1999July 2026
Median Sharpe
0.23
Dispersion
0.44
Best window
1.08

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.50.6%14.9%
3 yearsp.a.43.7%22.3%
5 yearsp.a.18.7%6.1%
10 yearsp.a.18.3%0.5%
Since inceptionp.a.11.4%2.9%
Calendar years
YearLong legLong-short
20267 mo29.3%20.2%
202534.8%-5.1%
202461.6%56.2%
202311.4%-22.4%
2022-20.0%10.6%
2021-0.9%-27.1%
202040.5%-9.7%
201925.2%-6.4%
2018-4.9%10.5%
201726.0%10.4%
20165.1%-19.1%
20152.2%17.0%
201417.0%4.7%
201326.3%-14.1%
201216.7%2.9%
2011-1.6%4.5%
201028.9%9.0%
200931.1%-3.4%
2008-39.1%13.6%
200727.1%26.3%
2006-0.1%-12.1%
200514.8%3.7%
20047.6%-3.7%
200338.0%-11.2%
2002-11.3%30.2%
2001-14.1%14.3%
2000-36.5%-37.7%
199989.9%89.6%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FINR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2022-05-12 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$9.95T

Methodology

The Foundry IntMom Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a IntMom signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.